Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2189158 Target Snapshot

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform · SINGLE PROTEIN · Mus musculus

155Compounds
27Assays
5Approved Drugs
155.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9JHG7. Use UniProt Q9JHG7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9JHG7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Protein anchor
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Review this target as Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, mapped to UniProt Q9JHG7. Sequence length is 1102 aa.

Protein source · UniProt accession via ChEMBL component mapping
UniProt Q9JHG7 Protein 1102 aa
Open protein block
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform as ChEMBL target CHEMBL2189158, mapped to UniProt Q9JHG7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL2189158
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9JHG7
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform is the right protein anchor across sources, using UniProt Q9JHG7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
UniProt AccessionQ9JHG7
Component TypeProtein
Sequence Length1102 aa

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform, mapped to UniProt Q9JHG7. Sequence length is 1102 aa.

Mapped IDQ9JHG7
Review namePhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

5
Approved
3
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC50152.0
EC503.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4558527 9.1 IC50 0.7943 Clinical
CHEMBL5071394 9.1 IC50 0.7943 Preclinical
CHEMBL5091438 9.1 IC50 0.7943 Preclinical
CHEMBL5090799 9.0 IC50 1.0 Preclinical
CHEMBL5076543 9.0 IC50 1.0 Preclinical
CHEMBL5077865 9.0 IC50 1.0 Preclinical
CHEMBL5086461 9.0 IC50 1.0 Preclinical
CHEMBL5088310 9.0 IC50 1.0 Preclinical
CHEMBL5088457 9.0 IC50 1.0 Preclinical
CHEMBL5089084 9.0 IC50 1.0 Preclinical
Distribution

pChEMBL Value Distribution

11
5.0
8
5.5
10
6.0
11
6.5
8
7.0
8
7.5
11
8.0
11
8.5
11
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

DUVELISIB
CHEMBL3039502
Approved 2018
CYCLOSPORINE
CHEMBL160
Approved 1983
Assay Landscape

Assay Landscape

27
Total Assays
101
Tested Compounds
2
Assay Types
Binding — 25 assays, 101 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 22 74 6.3
assay format 1 0
single protein format 1 0
tissue-based format 1 27 8.7
ADME — 2 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 1 5.9

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine